67035-76-1 ((1-PROPANAMINE, 3-DIBENZ[B,E]OXEPIN-11(6H)-YLIDENE-N-METHYL-, (3E)-)

1-PROPANAMINE, 3-DIBENZ[B,E]OXEPIN-11(6H)-YLIDENE-N-METHYL-, (3E)-;Monodesmethyldoxepin;Doxepin hydrochloride impurity C [EP];DOXEPIN_met004;1-Propanamine, 3-dibenz(b,E)oxepin-11(6H)-ylidene-N-methyl-, (3E)-;(E)-Desmethyldoxepin;NS00093640;Doxepin impurity C;PD040314;Desmethyldoxepin, (E)-;(E)-3-(Dibenzo(b,E)oxepin-11(6H)-ylidene)-N-methylpropan-1-amine;(E)-N-desmethyldoxepin;UNII-J7JTC0A5D6;SCHEMBL1695351;F498JSH8RR;DOXEPIN HYDROCHLORIDE IMPURITY C [EP IMPURITY];Desmethyl doxepin;1-Propanamine, 3-dibenz(b,E)oxepin-11(6H)-ylidene-N-methyl-, (E)-;Desmethyldoxepin;(3E)-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine;HVKCEFHNSNZIHO-MHWRWJLKSA-N;(E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine;DTXSID60217319;trans-Desmethyldoxepin;Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N-methyl-;67035-76-1;(E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine ((E,Z)-Desmethyldoxepin);J7JTC0A5D6;Q27281308;(3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N-methylpropan-1-amine;UNII-F498JSH8RR;1225-56-5;CHEBI:142340;N-Desmethyldoxepin;(E)desmethyldoxepin;(E)-3-dibenz[b,e]oxepin-11(6H)-ylidene-N-methyl-1-propanamine;Doxepin hydrochloride specified impurity C [EP];

HVKCEFHNSNZIHO-MHWRWJLKSA-N

1S/C18H19NO/c1-19-12-6-10-16-15-8-3-2-7-14(15)13-20-18-11-5-4-9-17(16)18/h2-5,7-11,19H,6,12-13H2,1H3/b16-10+

O1C2C=CC=CC=2/C(=C/CCNC)/C2C=CC=CC=2C1